A growing number of researchers think until there's an effective vaccine, the coronavirus will simply persist in the population, causing illness indefinitely. Better to squelch the spread instead.
This first wave of COVID-19 is not over. On the latest episode of GPB's Georgia Today, Andy Miller of Georgia Health News helps us understand where the pandemic might be headed in the state.
A single test that can give false reassurance sounds bad. But a $10 test for the coronavirus, if repeated daily, would discover real infections, say proponents of such tests as screening tools.
They're speaking out and leading protests to learn the fate of fathers and brothers who are among the many hundreds of disappeared Pakistanis — most of them men. Are they making a difference?
Exhausted leaders emerged from a marathon five days of talks with a rescue package to help member states weather their worst economic downturn since the Great Depression.
The country's citizenship minister and education minister separately announced their diagnoses on social media the same day that the country announced a grim new milestone in the pandemic.
Coronavirus vaccine studies in Great Britain and China have both reported encouraging results. These projects are on the vanguard of vaccine development, but now they are awaiting large-scale tests.
Leaders in the global group Girl Up went to their annual conference — virtually — last week. We interviewed some of the attendees to see what's changed during the coronavirus crisis.
Studies show children have lower rates of COVID-19 and have milder symptoms than adults. But there's less information on how much kids spread the coronavirus, which is key to safely reopen schools.
In their first face-to-face meeting since the pandemic began, European Union leaders hope to hammer out a 1.85 trillion euro ($2.1 trillion) EU budget and COVID-19 recovery plan.
U.S., British and Canadian intelligence agencies are reporting that Russian hackers are trying to steal information from health care organizations working on a potential coronavirus vaccine.